Biblio
Correction: Overexpression of VIRMA confers vulnerability to breast cancers via the mA-dependent regulation of unfolded protein response. Cell Mol Life Sci. 2023;80(8):204.
Overexpression of VIRMA confers vulnerability to breast cancers via the mA-dependent regulation of unfolded protein response. Cell Mol Life Sci. 2023;80(6):157.
LAT1 is a Putative Therapeutic Target in Endometrioid Endometrial Carcinoma. Int J Cancer. 2016.